GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » ROE %

Afrocentric Investment (JSE:ACT) ROE % : 9.84% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Afrocentric Investment's annualized net income for the quarter that ended in Dec. 2023 was R348 Mil. Afrocentric Investment's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was R3,533 Mil. Therefore, Afrocentric Investment's annualized ROE % for the quarter that ended in Dec. 2023 was 9.84%.

The historical rank and industry rank for Afrocentric Investment's ROE % or its related term are showing as below:

JSE:ACT' s ROE % Range Over the Past 10 Years
Min: 6.2   Med: 13.33   Max: 14.83
Current: 7.3

During the past 13 years, Afrocentric Investment's highest ROE % was 14.83%. The lowest was 6.20%. And the median was 13.33%.

JSE:ACT's ROE % is ranked better than
57.38% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.32 vs JSE:ACT: 7.30

Afrocentric Investment ROE % Historical Data

The historical data trend for Afrocentric Investment's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afrocentric Investment ROE % Chart

Afrocentric Investment Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.37 14.08 13.29 13.10 6.20

Afrocentric Investment Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.09 13.11 10.35 3.89 9.84

Competitive Comparison of Afrocentric Investment's ROE %

For the Medical Care Facilities subindustry, Afrocentric Investment's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afrocentric Investment's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's ROE % distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's ROE % falls into.



Afrocentric Investment ROE % Calculation

Afrocentric Investment's annualized ROE % for the fiscal year that ended in Jun. 2023 is calculated as

ROE %=Net Income (A: Jun. 2023 )/( (Total Stockholders Equity (A: Jun. 2022 )+Total Stockholders Equity (A: Jun. 2023 ))/ count )
=182.673/( (2448.394+3442.917)/ 2 )
=182.673/2945.6555
=6.20 %

Afrocentric Investment's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=347.522/( (3442.917+3623.015)/ 2 )
=347.522/3532.966
=9.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Afrocentric Investment  (JSE:ACT) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=347.522/3532.966
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(347.522 / 8768.772)*(8768.772 / 5560.117)*(5560.117 / 3532.966)
=Net Margin %*Asset Turnover*Equity Multiplier
=3.96 %*1.5771*1.5738
=ROA %*Equity Multiplier
=6.25 %*1.5738
=9.84 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=347.522/3532.966
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (347.522 / 524.36) * (524.36 / 2054.33) * (2054.33 / 8768.772) * (8768.772 / 5560.117) * (5560.117 / 3532.966)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6628 * 0.2552 * 23.43 % * 1.5771 * 1.5738
=9.84 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Afrocentric Investment ROE % Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Afrocentric Investment (JSE:ACT) Business Description

Traded in Other Exchanges
N/A
Address
37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.

Afrocentric Investment (JSE:ACT) Headlines

From GuruFocus

Enact Receives Ratings Upgrade from Fitch Ratings

By sperokesalga sperokesalga 04-25-2023

Enact Announces an Increase to Quarterly Dividend

By sperokesalga sperokesalga 05-01-2023

Enact Announces Quarterly Dividend

By sperokesalga sperokesalga 02-09-2023

Enact Releases 2023 Environmental, Social, and Governance (ESG) Roadmap

By Stock market mentor Stock market mentor 01-26-2023

Enact Receives Ratings Upgrade from Moody's

By sperokesalga sperokesalga 03-01-2023

Enact Receives Ratings Upgrade from S&P Global Ratings

By sperokesalga sperokesalga 02-16-2023

Wes Thompson elected to Constellation Boards

By Marketwired 07-12-2023